A guideline for the management of gastrointestinal stromal tumour (GIST)

Ian Judson, Michael Leahy, Jeremy Whelan, Paul Lorigan, Mark Verrill, Robert Grimer, Martin Robinson

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Gastrointestinal stromal tumour (GIST) is the commonest mesenchymal tumour to affect the gastrointestinal tract. Appropriate management requires accurate diagnosis and the skills of a multidisciplinary team. Surgery is the only curative treatment option and should be performed whenever feasible, by experienced personnel. For patients with advanced unresectable or metastatic disease, the receptor tyrosine kinase inhibitor imatinib offers effective therapy and can provide effective palliation for the majority of patients with this disease. The background to this recent development and a guideline for the management of GIST is proposed.
    Original languageEnglish
    Pages (from-to)83-87
    Number of pages4
    JournalSarcoma
    Volume6
    Issue number3
    DOIs
    Publication statusPublished - Sept 2002

    Fingerprint

    Dive into the research topics of 'A guideline for the management of gastrointestinal stromal tumour (GIST)'. Together they form a unique fingerprint.

    Cite this